Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Dr. Jesse W. HallChief Medical Officer | -9,33k | 41,15k | Derivative Exercise and Sale | 4,41 | 27,05k | - |
| 2026-05-01 | Dr. Jesse W. HallChief Medical Officer | 27,05k | 0,00 | Derivative Exercise and Retained Stock | - | 27,05k | - |
| 2026-04-23 | BML Capital Management, LLCUnternehmen | -300,00k | 1,36M | Verkauf | 4,53 | 13,95M | -2,11% |
| 2026-03-01 | Mr. Kevin BalthaserCFO | 1,70k | 0,00 | Derivative Exercise and Retained Stock | - | 187,45k | 0,91% |
| 2026-03-01 | Mr. Kevin BalthaserCFO | -677,00 | 1,94k | Derivative Exercise and Sale | 2,87 | 187,45k | - |
| 2026-02-03 | Mr. James LoeropChief Business Officer | 14,94k | 0,00 | Derivative Exercise and Retained Stock | - | 192,26k | 8,42% |
| 2026-02-03 | Mr. James LoeropChief Business Officer | -5,94k | 20,60k | Derivative Exercise and Sale | 3,47 | 192,26k | - |
| 2026-02-03 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | 44,86k | 0,00 | Derivative Exercise and Retained Stock | - | 1,54M | 2,99% |
| 2026-02-03 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | -18,61k | 64,58k | Derivative Exercise and Sale | 3,47 | 1,54M | - |
| 2026-02-03 | Dr. Hugh M. DavisPresident, COO & Director | 18,68k | 0,00 | Derivative Exercise and Retained Stock | - | 45,43k | 69,81% |
| 2026-02-03 | Mr. Kevin BalthaserCFO | 15,58k | 0,00 | Derivative Exercise and Retained Stock | - | 185,76k | 9,15% |
| 2026-02-03 | Mr. Kevin BalthaserCFO | -6,45k | 22,38k | Derivative Exercise and Sale | 3,47 | 185,76k | - |
| 2026-02-01 | Mr. James LoeropChief Business Officer | 22,81k | 0,00 | Derivative Exercise and Retained Stock | - | 177,32k | 14,77% |
| 2026-02-01 | Mr. James LoeropChief Business Officer | -10,69k | 37,51k | Derivative Exercise and Sale | 3,51 | 177,32k | - |
| 2026-02-01 | Mr. Kevin BalthaserCFO | 9,77k | 0,00 | Derivative Exercise and Retained Stock | - | 170,18k | 6,09% |
| 2026-02-01 | Mr. Kevin BalthaserCFO | -4,98k | 17,49k | Derivative Exercise and Sale | 3,51 | 170,18k | - |
| 2026-01-02 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | 19,20k | 0,00 | Derivative Exercise and Retained Stock | - | 1,50M | 1,30% |
| 2026-01-02 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | -9,95k | 28,66k | Derivative Exercise and Sale | 2,88 | 1,50M | - |
| 2025-12-31 | Mr. James LoeropChief Business Officer | 51,74k | 0,00 | Derivative Exercise and Retained Stock | - | 155,04k | 50,08% |
| 2025-12-31 | Mr. James LoeropChief Business Officer | -40,17k | 120,09k | Derivative Exercise and Sale | 2,88 - 3,01 | 155,04k | - |
| 2025-12-31 | Mr. Kevin BalthaserCFO | 67,81k | 0,00 | Derivative Exercise and Retained Stock | - | 160,41k | 73,22% |
| 2025-12-31 | Mr. Kevin BalthaserCFO | -26,65k | 79,62k | Derivative Exercise and Sale | 2,88 - 3,01 | 160,41k | - |
| 2025-12-02 | Dr. Hugh M. DavisPresident, COO & Director | 26,75k | 0,00 | Derivative Exercise and Retained Stock | - | 26,75k | - |
| 2025-06-06 | Dr. Andrew Newman SchiffIndependent Director | 4,79k | 0,00 | Derivative Exercise and Retained Stock | - | 13,96k | 52,29% |
| 2025-06-06 | Dr. Anand MehraIndependent Director | 4,79k | 0,00 | Derivative Exercise and Retained Stock | - | 714,82k | 0,68% |
| 2025-06-06 | Mr. Vincent J. MilanoIndependent Director | 4,79k | 0,00 | Derivative Exercise and Retained Stock | - | 17,32k | 38,27% |
| 2025-06-06 | Mr. William D. HumphriesIndependent Director | 4,79k | 0,00 | Derivative Exercise and Retained Stock | - | 33,53k | 16,68% |
| 2025-06-06 | Mr. Christopher P. MolineauxLead Independent Director | 4,79k | 0,00 | Derivative Exercise and Retained Stock | - | 57,96k | 9,02% |
| 2025-06-06 | Dr. Maxine GowenIndependent Director | 4,79k | 0,00 | Derivative Exercise and Retained Stock | - | 21,75k | 28,26% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
